Proof of efficacy for Seladelpar, a selective PPAR-δ agonist, in patients with primary biliary cholangitis non-responsive to ursodeoxycholic acid: results of an international Phase 2 randomised controlled clinical study
Hirschfield, G.M, Galambos, M.R, Bowlus, C.L, Swain, M.G, Doerffel, Y, Steinberg, A.S, Varga, M, Choi, Y.-J, Martin, R.L, Chera, H, McWherter, C.A, Boudes, P.F, Jones, D
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
FRI-378 - Proof of efficacy for Seladelpar, a selective PPAR-δ agonist, in patients with primary biliary cholangitis non-responsive to ursodeoxycholic acid: results of an international Phase 2 randomised controlled clinical study
Hirschfield, G.M., Galambos, M.R., Bowlus, C.L., Swain, M.G., Doerffel, Y., Steinberg, A.S., Varga, M., Choi, Y.-J., Martin, R.L., Chera, H., McWherter, C.A., Boudes, P.F., Jones, D.
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article